meglitinide has been researched along with Weight Gain in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, SN; Lamos, EL; Stein, SA | 1 |
Hamdy, O; Mitri, J | 1 |
Purnell, JQ; Weyer, C | 1 |
Hermansen, K; Mortensen, LS | 1 |
4 review(s) available for meglitinide and Weight Gain
Article | Year |
---|---|
Sulfonylureas and meglitinides: historical and contemporary issues.
Topics: Animals; Benzamides; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Glyburide; History, 20th Century; History, 21st Century; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Ischemic Preconditioning; Neoplasms; Risk Assessment; Risk Factors; Sulfonylurea Compounds; Treatment Outcome; Weight Gain | 2013 |
Diabetes medications and body weight.
Topics: Abdominal Fat; Benzamides; Body Weight; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Exenatide; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Metformin; Obesity; Peptides; Randomized Controlled Trials as Topic; Sulfonylurea Compounds; Thiazolidinediones; Venoms; Weight Gain; Weight Loss | 2009 |
Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity.
Topics: Amyloid; Benzamides; Biguanides; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Islet Amyloid Polypeptide; Obesity; Peptide Fragments; Protein Precursors; Sulfonylurea Compounds; Thiazolidinediones; Weight Gain | 2003 |
Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.
Topics: Amyloid; Benzamides; Biguanides; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islet Amyloid Polypeptide; Obesity; Sulfonylurea Compounds; Thiazolidinediones; Weight Gain | 2007 |